Related Experiment Video
Updated: Jan 29, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
Jun Yan1,2,3, Qingnan Zhao3, Konrad Gabrusiewicz4
1Center for Brain Disorders Research, Capital Medical University, Beijing, 100069, China.
Abstract:
The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.
Related Concept Videos
Milgram's Obedience to Authority
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Eukaryotic Promoter Region
Distance Corrections
Power Factor Correction
Neurons: The Cell Body and the Dendrites

